Clinical Trial Update: Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating omega-3 fatty acids (Lovaza) for hypertriglyceridemia associated with second-generation antipsychotics. Results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Hypercholesterolemia
• Hypertriglyceridemia
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: High Triglycerides, Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2016-04-04